Literature DB >> 16765665

Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats.

Silvina R Mastaglia1, Gretel G Pellegrini, Patricia M Mandalunis, Macarena M Gonzales Chaves, Silvia M Friedman, Susana N Zeni.   

Abstract

The present study was carried out to obtain an experimental model of vitamin D (vit D) insufficiency and established osteopenia (experiment 1) to then investigate whether vit D status, i.e. normal or insufficient, interferes with bone mass recovery resulting from bisphosphonate therapy (experiment 2). Rats (n = 40) underwent OVX (n = 32) or a sham operation (n = 8). The first 15 days post-surgery, all groups were kept under fluorescent tube lighting and fed a diet containing 200 IU% vit D (+D). They were then assigned during an additional 45 days to receive either +D or a diet lacking vit D (-D) and kept under 12 h light/dark cycles using fluorescent or red lighting. Serum 25HOD was significantly lower in -D rats (P < 0.0001). The type of lighting did not induce differences in 25OHD, calcium (sCa), phosphorus (sP), bone alkaline phosphatase (b-AL), CTX, bone density or histology. No osteoid was observed in undecalcified bone sections. Experiment 2 (105 days): rats were fed either +D or -D according to experiment 1 and were treated with either placebo or 16 mug olpadronate (OPD)/100 g rat/week during the last 45 days. Whereas 25HOD was significantly lower (P < 0.0001) in -D/OPD than in +D/OPD rats, no significant differences in sCa, sP, b-AL or CTX were observed. OPD prevented the loss of lumbar spine (LS) and proximal tibia (PT) BMD and the decrease in bone volume (BV/TV) (P < 0.05) and in the number of trabeculae observed in untreated rats. However, +D/OPD animals presented significantly higher values of LS BMD, PT BMD and BV/TV than -D/OPD rats (P < 0.05). No osteoid was observed in undecalcified sections of bone. In summary, this is the first experimental study to provide evidence that differences in vit D status may affect the anticatabolic response to bisphosphonate treatment. However, the molecular mechanism through which vit D insufficiency reduces the effect of the aminobisphosphonate remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765665     DOI: 10.1016/j.bone.2006.04.015

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Effect of a mixture of GOS/FOS® on calcium absorption and retention during recovery from protein malnutrition: experimental model in growing rats.

Authors:  Gabriel Bryk; Magalí Zeni Coronel; Carlos Lugones; Patricia Mandalunis; María Esther Rio; Ariel Felix Gualtieri; María Luz Pita Martín de Portela; Susana Noemí Zeni
Journal:  Eur J Nutr       Date:  2015-09-26       Impact factor: 5.614

2.  Association between vitamin D3 supplementation and serum 25-hydroxyvitamin D levels in older individuals residing in long-term care in Ontario, Canada.

Authors:  George Ioannidis; Courtney C Kennedy; Joanne Dykeman; Sandra Dudziak; Alexandra Papaioannou
Journal:  J Am Geriatr Soc       Date:  2012-05       Impact factor: 5.562

3.  Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.

Authors:  G Y Liu; G L Cao; F M Tian; H P Song; L L Yuan; L D Geng; Z Y Zheng; L Zhang
Journal:  Osteoporos Int       Date:  2017-08-14       Impact factor: 4.507

4.  Diagnosis and management of mineral metabolism in CKD.

Authors:  Ishir Bhan; Anil Dubey; Myles Wolf
Journal:  J Gen Intern Med       Date:  2010-03-30       Impact factor: 5.128

5.  Effect of dietary calcium (Ca) on body composition and Ca metabolism during growth in genetically obese (β) male rats.

Authors:  Clarisa Marotte; Adriana Weisstaub; Gabriel Bryk; Maria C Olguin; Marta Posadas; Diego Lucero; Laura Schreier; Maria Luz Pita Martín de Portela; Susana N Zeni
Journal:  Eur J Nutr       Date:  2012-03-29       Impact factor: 5.614

Review 6.  Patient adherence to osteoporosis medications: problems, consequences and management strategies.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Lisa Dolovich; Elaine Lau; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  The effect of calcium and vitamin D supplementation on osteoporotic rabbit bones studied by vibrational spectroscopy.

Authors:  Athina Lani; Nikolaos Kourkoumelis; Gerasimos Baliouskas; Margaret Tzaphlidou
Journal:  J Biol Phys       Date:  2014-07-09       Impact factor: 1.365

8.  Low dietary calcium and obesity: a comparative study in genetically obese and normal rats during early growth.

Authors:  Clarisa Marotte; Gabriel Bryk; Macarena M S Gonzales Chaves; Fima Lifshitz; Maria Luz Pita Martín de Portela; Susana N Zeni
Journal:  Eur J Nutr       Date:  2013-09-06       Impact factor: 5.614

9.  Effect of a combination GOS/FOS® prebiotic mixture and interaction with calcium intake on mineral absorption and bone parameters in growing rats.

Authors:  Gabriel Bryk; Magalí Zeni Coronel; Gretel Pellegrini; Patricia Mandalunis; María Ester Rio; María Luz Pita Martín de Portela; Susana Noemí Zeni
Journal:  Eur J Nutr       Date:  2014-09-21       Impact factor: 5.614

10.  A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Lora Giangregorio; George Ioannidis; Janet Pritchard; David A Hanley; Leonardo Farrauto; Justin DeBeer; Jonathan D Adachi
Journal:  BMC Musculoskelet Disord       Date:  2011-06-20       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.